Control group:Saline was transfused

A single blind, placebo-controlled, single center, parallel group study to evaluate the efficacy and safety of cord blood mononuclear cell therapy in patients with autism (aged 2-7 years)

A randomized controlled study evaluating the efficacy of umbilical cord blood mononuclear cells in the treatment of children (aged 2-7 years) with cerebral palsy